A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral Sclerosis
Clinical trial NCT04948645 · TERMINATED
Trial details
- NCT number
- NCT04948645
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-22
- Primary completion
- 2025-07-15
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.